Metabolic Syndrome Observation on a Regional Basis

Completed

• Conditions: Metabolic Syndrome

• Registration Number: NCT00933010
• Lead Sponsor: AstraZeneca

Brief Summary

The aim of the study is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-07-02
• Study First Submitted QC: 2009-07-02
• Study First Posted: 2009-07-07
• Study Start: 2009-10
• Status Verified: 2010-10
• Primary Completion: 2010-10
• Study Completion: 2010-10
• Last Update Submitted: 2010-10-12
• Last Update Posted: 2010-10-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1600

Inclusion Criteria

• Patient aged between 18 and 75 years
• Signed Informed consent
• Laboratory analysis (lipidic profile and glycemia) performed in the last year

Exclusion Criteria

• Pregnancy or breast feeding
• Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs
• Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of Metabolic Syndrome in Primary Care Population	July 2009 - March 2010
Concomitant presence of other CV risk factors	July 2009 - March 2010

Trial Locations

Locations (2)

Research; 🇮🇹 Foligno, Italy

Research Site; 🇮🇹 Terni, Italy